Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...

With several of these drugs going off patent in the next few years, OneSource is poised to see big growth in the generic ...

President-elect Donald Trump's pick for health secretary, Robert F. Kennedy Jr., said Thursday he believes anti-obesity drugs ...

Ms. Gantt is now missing her colon and has an ileostomy bag attached to her abdomen. Now, she is suing Novo Nordisk, claiming that the drug's labels do not warn of all serious side effects, including ...

Packaged-food giant Conagra Foods is hoping to appeal to people taking weight-loss drugs with frozen entrees like chicken fettuccini alfredo or meatball marinara. Starting in January, 26 items in ...

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss ...

Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both ...

Here are five major developments and breakthroughs in cardiology research and technology in 2024: ...

Here are 10 major orthopedic studies conducted in 2024 to know: ...

If one is larger than everyone around, it’s mentally comforting that the condition is called obesity and is transitioning ...

Mahmoud Nassar, MD, PhD, a trainee in the endocrinology, diabetes and metabolism fellowship program at the Jacobs School of Medicine and Biomedical Sciences, received several prestigious outstanding ...